1. Barker E, Mokyr MB (1986) Specificity of the generation and expression of enhanced antitumor cytotoxicity by spleen cells from melphalan (L-PAM) treated MOPC-315 tumor bearers. Proc Am Assoc Cancer Res 27:357
2. Baumann MA, Milson TJ, Patrick CW, Libnoch JA, Keller RH (1986) Correlation of circulating natural killer cell count with prognosis in large cell lymphoma. Cancer 57:2309?2312
3. Berd D, Mastrangelo MJ, Engstrom PF, Paul A, Maguire H (1982) Augmentation of the human immune response by cyclophosphamide. Cancer Res 42:4862?4866
4. Berd D, Maguire HC, Mastrangelo MJ (1984) Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer. Cancer Res 44:1275?1280
5. Borel JF, Feuerr C, Magnée C, Stähelin H (1977) Effects of the new antilymphocytic peptide cyclosporin A in animals. Immunology 32:1017?1025